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Endoleaks combined with increasing sac size following endovascular aneurysm repair require reintervention to prevent
secondary aneurysm rupture. For standard infrarenal stent grafts, there are multiple treatment strategies available.
However, in the presence of a fenestrated or branched stent graft, options are limited. We describe a novel challenging
approach to treat a persistent type Ia endoleak by placing a second fenestrated stent graft into the pre-existing one, thus,
realigning the graft and extending the proximal sealing zone. (J Vasc Surg 2014;59:814-6.)Fenestrated stent grafts have become accepted as a safe
technique to treat aneurysms involving aortic side
branches.1,2 They do, however, create other challenges
especially in the treatment of type Ia and type III endoleaks
where aortic side branches need to be protected.3 Conver-
sion to open surgery often is unfeasible due to procedure
complexity and patient ﬁtness. Only a few experimental
endovascular treatments are reported.4,5
We present a case of a patient who had multiple unsuc-
cessful procedures to treat a persistent type Ia endoleak
after a fenestrated endovascular aneurysm repair. He was
successfully treated by placing a second fenestrated endog-
raft inside the existing one, thus, realigning the whole stent
graft. This technique to our knowledge had neither been
described nor performed before.
CASE REPORT
In 2007, a 72-year-old gentleman was referred to our service
with a 6-cm infrarenal abdominal aortic aneurysm. His past
medical history included type II diabetes and severe ischemic heart
disease. Preoperative assessment classiﬁed the patient in the high-
risk category and an endovascular solution was pursued. A short
neck necessitated a custom-made device (CMD) with two renal
fenestrations. This was implanted without complications. The
patient was followed up with regular computed tomographicthe Division of Vascular Surgery, Fremantle Hospital.
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://dx.doi.org/10.1016/j.jvs.2013.04.006angiograms (CTAs). In 2010, a slight increase in sac size to 6.3
cm was noted without evidence of an endoleak. In late 2011 the
sac increased to 7.1 cm with a visible type Ia endoleak. The sac
and neck were embolized with Onyx (EV3 Endovascular Inc,
Plymouth, Minn) via a catheter from within the graft with the
tip positioned between the graft and the aortic wall. However, 4
months later the sac had grown to 7.8 cm, and a new type II
lumbar endoleak was noted. Consequently, lumbar coil emboliza-
tion and additional Onyx injection was performed. The 3-month
follow-up showed an 8.1 cm sac with a persistent type Ia endoleak
(Fig 1) attributable to pararenal aortic dilatation. The decision was
made to place another fenestrated graft inside the existing one with
the view to extend the proximal sealing zone.
A four-fenestration CMD (Cook Inc, Bloomington, Ind) was
chosen (Fig 2). In addition to a standard fenestrated graft, double
diameter reducing ties and preloaded renal fenestrations were
incorporated. Double reducing ties will decrease the diameter of
the graft after unsheathing, improving manoeuvrability and aiding
alignment within the conﬁned space of the previous graft. A pre-
loaded system incorporates a through-and-through wire through
both renal fenestrations over which sheaths can be positioned
directly in the fenestration. These supported sheaths aid cannula-
tion of the target vessel with a “curly Q” cannulation catheter
(Cook Inc). After successful renal cannulation, the through-and-
through wire is removed and the sheaths can then be advanced
into the renal arteries.
In this case, the graft was introduced percutaneously through
the right common femoral artery and slowly unsheathed rotating
each fenestration in its strut complex to align with its target vessel.
The renal vessels were then cannulated with the aid of the pre-
loaded system. The left renal artery posed a particular challenge
as the previous renal stent origin was directed more anterior
than anticipated. Additional anterior graft rotation enabled
successful cannulation. The superior mesenteric fenestration and
artery were accessed with a 7F sheath introduced through the
left common femoral artery. The celiac artery (CA) could not be
Fig 1. Angiographic conﬁrmation of type Ia endoleak. A diag-
nostic catheter is introduced from femoral with its tip positioned
between the graft and the aortic wall (broad white arrow). The
endoleak is clearly visualized (narrow black arrow). Both renal
stents are in situ (broad black arrows).
Fig 2. Illustration of the operative plan. The initial fenestrated
graft is outlined in red; the second fenestrated device is outlined in
black. 1, Celiac artery (CA) fenestration. 2, Bare proximal ﬁxation
stent of initial graft. 3, Superior mesenteric artery (SMA) fenes-
tration. 4, Renal fenestrations. 5, In situ covered stents in the renal
arteries. 6, Limb extensions landing in the common iliac arteries.
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tion and a signiﬁcant stenosis 2 cm from its origin. Hence, the
sheaths were advanced into the superior mesenteric artery (SMA)
and renal arteries alone. As the sheaths guide the fenestrations
directly onto the target vessels and the three-point ﬁxation gives
rotational stability, the authors were satisﬁed that good alignment
between the CA fenestration and artery would be achieved without
prior cannulation. Consequently, the diameter-reducing ties were
released, the top cap removed, and the graft fully deployed.
A 5-  22-mm V12 covered stent (Atrium Medical Corporation,
Hudson, NH) was placed in the right and a 6-  22-mm V12
in the left renal artery. The protruding section into the main
body was ﬂared with a 7- and 8-mm balloon, respectively. The
SMA was stented with an 8-  38-mm V12 that was ﬂared to
10 mm. As anticipated, subsequent cannulation of the CA via
a left axillary approach was found to be straightforward and an
8-  22-mm V12 stent was inserted.
The ﬁnal angiogram demonstrated good ﬂow in all four
branches. There was no evidence of an endoleak. The postproce-
dure CTA conﬁrms renal, SMA, and CA patency without any
further endoleak (Fig 3).
DISCUSSION
The presented case proved to be highly complex. It is
the authors’ belief that the type II endoleak seen after
the ﬁrst sac embolization actually was the result of
a continuing type Ia endoleak, which was not detected or
masked by the type II on CTA. It can be argued that addi-
tional imaging (ie, contrast ultrasound to determine ﬂowdirection) may have given further information and altered
the second Onyx injection site.6 Several other treatment
options were considered. All open surgical options were
deemed too high risk for this patient, hence, only endovas-
cular solutions were thought feasible. There were two
major endovascular approaches considered. These were
either proximal graft extension using the snorkel technique
to preserve side branches7 or placement of a second CMD.
Several anatomic challenges had to be taken into account.
The original CMD consisted of two renal fenestrations and
had a bare proximal stent with aortic ﬁxation hooks. The
struts crossed over the SMA ostium on either side and
landed adjacent to the bottom edge of the CA (Fig 2).
The CA came off the aorta at a downward angle with
a signiﬁcant stenosis just after the origin. Both factors
were thought to make celiac cannulation from below difﬁ-
cult, and the potential for an axillary approach was noted.
Fig 3. The three-dimensional reconstruction of the completion
computed tomographic angiogram (CTA) shows the ﬁnal
conﬁguration. 1, Patent celiac artery (CA). 2, Patent superior
mesenteric artery (SMA). 3, Patent renal arteries. 4, Previous Onyx
injection site.
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approach; therefore, they protruded into the graft lumen
at a moderate downward angulation.
As opposed to a CMD, the snorkel technique would
have given the safety of securing access by prior cannula-
tion of all vessels before deployment of the extension
cuff. However, the distance between the renal arteries
and the SMA was deemed not long enough to create
a secure distal seal. Therefore, the cuff would have had to
extend beyond the renal arteries necessitating a four-
snorkel technique. This would require the renal stents to
go through a greater than 90 degree bend, which would
compromise stent patency and also a potential seal. For
the authors, the best option to create an adequate sealing
zone ensuring physiological ﬂow to the aortic brancheswas the placement of a second fenestrated stent graft inside
the existing one.
This strategy necessitated a four-vessel fenestrated
CMD as described above. Meticulous preoperative plan-
ning incorporating Aquarius (TeraRecon Inc, Foster City,
Calif) imaging software and extensive experience with
fenestrated grafting allowed a successful outcome of a difﬁ-
cult clinical problem.
CONCLUSIONS
The “fenestrated inside fenestrated” approach seems to
be a feasible technique to treat persistent type I endoleaks
after previous fenestrated endovascular aneurysm repair.
However, as this technique is technically very challenging
and requires a high operator experience, it should be
reserved for cases where all other treatment options have
been exhausted.REFERENCES
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